Sectors

The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

The Alibaba-backed medical data software provider has reportedly halted plans for a $211m offering due to regulatory concerns.

The fund will invest in companies linked to École Polytechnique, including spinouts, alumni-founded startups or businesses incubated by the school.

Medison has contributed to a private placement in support of portfolio company Alpha Tau Medical’s $1bn reverse merger with Healthcare Capital Corp.

The Sanofi-backed vaccine developer has filed to float on the Nasdaq Global Select Market and set a placeholder target of $100m.

GV contributed to the precision oncology platform developer's series A round, which will fund technology development and clinical studies.

Novo and Sanofi Ventures both participated in a series A round for the neurodegenrative disease drug developer, which is led by EIRs at Novo Seeds.

The musculoskeletal healthcare provider has added cash from Intermountain Healthcare, Ascension Ventures and Echo Health Ventures to a round now surpassing $50m.

NTT Docomo Ventures and 31Ventures returned for the smart key system provider’s $15.8m round, which included Kokuyo, NN Corporate Capital and JR East Start Up.

Colopl, Fuji Media, HTG, Kosei Pharma, Mori Trust, Nomura, SBS and Vector all backed a $20.5m round for the Askul and Ricoh-backed lending and borrowing marketplace..

Atlas Sensor Technologies, GrowFlux, Motorleaf, New West Genetics and SunPath have been selected to participate in Wells Fargo’s Innovation Incubator.